Posts with tag: social media marketing
In a legal battle, Elon Musk and OpenAI CEO Sam Altman clash over Musk's $97.4 billion bid for the AI startup. Altman claims Musk's offer undermines his lawsuit against OpenAI, while Musk counters that he'd withdraw the bid if OpenAI remained a charity. The legal dispute revolves around OpenAI's restructuring and alleged antitrust violations.
Published on: February 13, 2025, 05:04 PM UTC
Shareholders reject Siemens' plan to continue virtual AGMs
Published on: February 13, 2025, 05:01 PM UTC
Iridium Communications Inc. (IRDM) reports Q4 profit of $36.3 million, exceeding Wall Street expectations, with revenue of $213 million.
Published on: February 13, 2025, 01:09 PM UTC
Ceva reported a Q4 loss of $1.7 million, matching estimates, with revenue of $29.2 million exceeding forecasts. For the year, its loss narrowed to $8.8 million, with revenue of $106.9 million.
Published on: February 13, 2025, 01:09 PM UTC
Thomson Reuters to shift its US stock listing from the New York Stock Exchange to the Nasdaq, effective February 25, with no impact on its Toronto Stock Exchange-listed shares.
Published on: February 13, 2025, 01:08 PM UTC
After speaking with Vladimir Putin, President Trump plans to negotiate an end to the war in Ukraine. European leaders worry that Trump's conciliatory stance towards Russia may give in to Putin's demands without offering anything in return and that any deal made without Europe's involvement will not be lasting.
Published on: February 13, 2025, 01:08 PM UTC
Datadog, Inc. reported a Q4 net income of $45.6 million, beating Wall Street expectations of 43 cents per share with 49 cents per share. The data analytics and cloud monitoring company's revenue reached $737.7 million, topping forecasts of $711.6 million.
Published on: February 13, 2025, 01:06 PM UTC
Hanesbrands: Q4 2024 Revenue Miss, EPS Beat; Guidance Disappoints
Published on: February 13, 2025, 01:04 PM UTC
Funding cuts to the National Institutes of Health (NIH) raise concerns over potential impacts on drug research and biomedical innovation, with experts warning of mass layoffs, project cancellations, and less US dominance in science and medicine.
Published on: February 13, 2025, 12:02 PM UTC
EPS beats expectations, analyst sees conservatism in new CEO's guidance.
Published on: February 13, 2025, 11:02 AM UTC